Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
OSUR
#2938
OraSure Technologies Inc
3.1
5
+1.94%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.94%
Changement Mensuel
+16.24%
Evolution sur 6 mois
-5.69%
Changement Annuel
-6.80%
Clôture Précédente
3.0
9
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.1
5
Volume
50
Marchés
Actions des Marchés US
Soins de Santé
OSUR
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
71.95 M
72.3 M
73.24 M
73.8 M
74.8 M
—
Valuation ratios
Enterprise value
600.74 M
511.57 M
266.86 M
320.63 M
2.27 M
5.39 M
Price to earnings ratio
-48.11
-27.16
-19.16
11.5
-13.88
-30.23
Price to sales ratio
4.16
2.68
0.9
1.52
1.45
6.51
Price to cash flow ratio
123.05
17.68
7.36
4.35
9.82
27.23
Price to book ratio
1.79
1.64
0.96
1.43
0.65
1.1
Enterprise value to EBITDA ratio
142.69
342.41
-34.89
5.98
-0.13
-0.2
Profitability ratios
Return on assets %
-0.03
-0.05
-0.04
0.11
-0.04
-0.13
Return on equity %
-0.04
-0.06
-0.05
0.12
-0.05
-0.16
Return on invested capital %
24.71
8.55
-32.51
58.63
-58.98
-131.41
Gross margin %
59.32
50.33
38.1
42.33
42.72
162.9
Operating margin %
-3.01
-4.35
-5.92
8.06
-15.2
-209.57
EBITDA margin %
2.45
0.64
-1.97
13.22
-9.35
-176.38
Net margin %
-8.69
-9.84
-4.63
13.23
-10.49
-196.08
Liquidity ratios
Quick ratio
5.53
3.46
3.26
8.57
8.93
32.4
Current ratio
6.21
4.24
4.63
9.77
9.95
36.44
Inventory turnover
2.54
2.73
3.21
3.25
2.6
2.14
Asset turnover
0.43
0.51
0.86
0.87
0.39
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.09
-0.49
-0.65
1.9
0.37
-0.53
EBIT per share
-0.08
-0.14
-0.32
0.44
-0.38
-0.86
EBITDA per share
0.06
0.02
-0.11
0.72
-0.23
-0.72
Total debt per share
—
—
—
—
—
—
Cash per share
3.1
2.13
1.53
3.9
3.6
12.96
Net current asset value per share
4.28
4.01
4.49
5.2
4.48
16.52
Tangible book value per share
5.04
4.53
4.37
5.29
4.74
19.5
Working capital per share
3.59
3.06
3.52
4.66
4.03
14.62
Book value per share
5.9
5.29
5.02
5.79
5.51
20.79
OraSure Technologies Inc
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
Nouvelles
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
Le BPA de OraSure égale les attentes, le CA en dessous des prévisions
OraSure earnings matched, revenue fell short of estimates
OraSure’s HIV self-test receives Health Canada license
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Altai Capital nomme deux administrateurs au conseil d’OraSure Technologies
Altai Capital nominates two directors for OraSure Technologies board
Altai Capital nomme deux administrateurs au conseil d’OraSure face à des inquiétudes
Altai Capital nominates two directors to OraSure board amid concerns
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure submits FDA applications for rapid STI test and collection device
NeoGenomics nomme le vétéran du diagnostic Jack Kenny à son conseil d’administration